Broussonetia papyrifera pollen

Identification

Summary

Broussonetia papyrifera pollen is an extract from Broussonetia papyrifera pollen used in allergy testing.

Generic Name

Broussonetia papyrifera pollen

DrugBank Accession Number

DB10736

Background

Broussonetia papyrifera pollen is the pollen of the Broussonetia papyrifera plant. Broussonetia papyrifera pollen is mainly used in allergenic testing.

Type

Biotech

Groups

Approved

Biologic Classification

Allergenics
Allergen Extract

Synonyms

• mulberry pollen extract

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs

Not Available

Interactions

Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Brand Name Prescription Products

Name	Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	Region	Image
Mulberry	Injection, solution	0.05 g/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Mulberry	Injection, solution	20000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Mulberry	Injection, solution	10000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Mulberry	Injection, solution	20000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable
Mulberry	Injection, solution	10000 [PNU]/1mL	Intradermal; Subcutaneous	Nelco Laboratories, Inc.	1972-08-29	Not applicable

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Mulberry Mixture	Broussonetia papyrifera pollen (0.0167 g/1mL) + Morus alba pollen (0.0167 g/1mL) + Morus rubra pollen (0.0167 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1974-03-23	Not applicable
Treatment Set TS347226	Broussonetia papyrifera pollen (0.00067 g/1mL) + Amaranthus retroflexus pollen (0.002 g/1mL) + Avena sativa pollen (0.00008 g/1mL) + Carya illinoinensis pollen (0.00004 g/1mL) + Carya tomentosa pollen (0.00004 g/1mL) + Chenopodium album pollen (0.002 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Felis catus hair (80 [BAU]/1mL) + Festuca pratensis pollen (160 [BAU]/1mL) + Juglans nigra pollen (0.0004 g/1mL) + Morus alba pollen (0.00067 g/1mL) + Morus rubra pollen (0.00067 g/1mL) + Pascopyrum smithii pollen (0.00008 g/1mL) + Phleum pratense pollen (160 [BAU]/1mL) + Plantago lanceolata pollen (0.002 g/1mL) + Platanus occidentalis pollen (0.002 g/1mL) + Populus alba pollen (0.001 g/1mL) + Populus nigra pollen (0.001 g/1mL) + Quercus alba pollen (0.002 g/1mL) + Rumex acetosella pollen (0.002 g/1mL) + Sorghum halepense pollen (0.00008 g/1mL) + Urtica dioica pollen (0.002 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1986-10-31	Not applicable
Treatment Set TS347227	Broussonetia papyrifera pollen (0.00013 g/1mL) + Acer negundo pollen (0.0004 g/1mL) + Betula populifolia pollen (0.002 g/1mL) + Canis lupus familiaris hair (0.002 g/1mL) + Carya illinoinensis pollen (0.00004 g/1mL) + Carya tomentosa pollen (0.00004 g/1mL) + Cochliobolus sativus (0.002 g/1mL) + Cynodon dactylon pollen (400 [BAU]/1mL) + Felis catus hair (400 [BAU]/1mL) + Festuca pratensis pollen (4000 [BAU]/1mL) + Fraxinus americana pollen (0.002 g/1mL) + Juglans nigra pollen (0.002 g/1mL) + Juniperus virginiana pollen (0.002 g/1mL) + Morus alba pollen (0.00013 g/1mL) + Morus rubra pollen (0.00013 g/1mL) + Pascopyrum smithii pollen (0.002 g/1mL) + Phleum pratense pollen (800 [BAU]/1mL) + Populus alba pollen (0.001 g/1mL) + Populus nigra pollen (0.001 g/1mL) + Quercus alba pollen (0.0004 g/1mL) + Salix nigra pollen (0.002 g/1mL) + Sorghum halepense pollen (0.0004 g/1mL)	Injection, solution	Intradermal; Subcutaneous	Antigen Laboratories, Inc.	1986-10-31	Not applicable

Categories

Drug Categories

• Cell-mediated Immunity
• Increased Histamine Release
• Increased IgG Production
• Non-Standardized Pollen Allergenic Extract

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

51I6N3XIML

CAS number

Not Available

References

General References

Not Available

External Links

PubChem Substance

347910865

RxNav

899593

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Injection, solution	Intradermal; Subcutaneous	0.1 g/1mL
Injection, solution	Intradermal; Subcutaneous	10000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	20000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous	40000 [PNU]/1mL
Injection, solution	Intradermal; Subcutaneous
Injection, solution	Intradermal; Subcutaneous	0.05 g/1mL
Injection, solution	Percutaneous; Subcutaneous	1 g/20mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.001 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.05 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	0.1 g/1mL
Solution	Intradermal; Percutaneous; Subcutaneous	40000 [PNU]/1mL

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53